Home Applications 016822 Application 016822
Type NDA
Sponsor B BRAUN Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 FREAMINE 8.5% AMINO ACIDS INJECTABLE;INJECTION 8.5% (8.5GM/100ML) No No 002 FREAMINE II 8.5% AMINO ACIDS INJECTABLE;INJECTION 8.5% (8.5GM/100ML) No No 003 FREAMINE III 3% W/ ELECTROLYTES AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE INJECTABLE;INJECTION 3%;54MG/100ML;40MG/100ML;150MG/100ML;200MG/100ML;120MG/100ML No No 004 FREAMINE III 8.5% AMINO ACIDS INJECTABLE;INJECTION 8.5% (8.5GM/100ML) No No 005 FREAMINE III 10% AMINO ACIDS INJECTABLE;INJECTION 10% (10GM/100ML) No No 006 FREAMINE HBC 6.9% AMINO ACIDS INJECTABLE;INJECTION 6.9% (6.9GM/100ML) No No 007 FREAMINE III 8.5% W/ ELECTROLYTES AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE INJECTABLE;INJECTION 8.5%;110MG/100ML;230MG/100ML;10MG/100ML;440MG/100ML;690MG/100ML No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 7 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N016822-001 FREAMINE 8.5% AMINO ACIDS 8.5% (8.5GM/100ML) INJECTABLE / INJECTION Approved before 1982 N016822-002 FREAMINE II 8.5% AMINO ACIDS 8.5% (8.5GM/100ML) INJECTABLE / INJECTION Approved before 1982 N016822-003 FREAMINE III 3% W/ ELECTROLYTES AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE 3%;54MG/100ML;40MG/100ML;150MG/100ML;200MG/100ML;120MG/100ML INJECTABLE / INJECTION Approved before 1982 N016822-004 FREAMINE III 8.5% AMINO ACIDS 8.5% (8.5GM/100ML) INJECTABLE / INJECTION Approved before 1982 N016822-005 FREAMINE III 10% AMINO ACIDS 10% (10GM/100ML) INJECTABLE / INJECTION Approved before 1982 N016822-006 FREAMINE HBC 6.9% AMINO ACIDS 6.9% (6.9GM/100ML) INJECTABLE / INJECTION 1983-05-17 N016822-007 FREAMINE III 8.5% W/ ELECTROLYTES AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE 8.5%;110MG/100ML;230MG/100ML;10MG/100ML;440MG/100ML;690MG/100ML INJECTABLE / INJECTION 1988-07-01
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 7 of 8 · 308 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N016822-003 FREAMINE III 3% W/ ELECTROLYTES 3%;54MG/100ML;40MG/100ML;150MG/100ML;200MG/100ML;120MG/100ML INJECTABLE / INJECTION Approved before 1982 9b2671bbb829…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N016822-004 FREAMINE III 8.5% 8.5% (8.5GM/100ML) INJECTABLE / INJECTION Approved before 1982 9b2671bbb829…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N016822-005 FREAMINE III 10% 10% (10GM/100ML) INJECTABLE / INJECTION Approved before 1982 9b2671bbb829…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N016822-006 FREAMINE HBC 6.9% 6.9% (6.9GM/100ML) INJECTABLE / INJECTION 1983-05-17 9b2671bbb829…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N016822-007 FREAMINE III 8.5% W/ ELECTROLYTES 8.5%;110MG/100ML;230MG/100ML;10MG/100ML;440MG/100ML;690MG/100ML INJECTABLE / INJECTION 1988-07-01 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N016822-001 FREAMINE 8.5% 8.5% (8.5GM/100ML) INJECTABLE / INJECTION Approved before 1982 a67488948f0b…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N016822-002 FREAMINE II 8.5% 8.5% (8.5GM/100ML) INJECTABLE / INJECTION Approved before 1982 a67488948f0b…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N016822-003 FREAMINE III 3% W/ ELECTROLYTES 3%;54MG/100ML;40MG/100ML;150MG/100ML;200MG/100ML;120MG/100ML INJECTABLE / INJECTION Approved before 1982 a67488948f0b…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N016822-004 FREAMINE III 8.5% 8.5% (8.5GM/100ML) INJECTABLE / INJECTION Approved before 1982 a67488948f0b…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N016822-005 FREAMINE III 10% 10% (10GM/100ML) INJECTABLE / INJECTION Approved before 1982 a67488948f0b…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N016822-006 FREAMINE HBC 6.9% 6.9% (6.9GM/100ML) INJECTABLE / INJECTION 1983-05-17 a67488948f0b…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N016822-007 FREAMINE III 8.5% W/ ELECTROLYTES 8.5%;110MG/100ML;230MG/100ML;10MG/100ML;440MG/100ML;690MG/100ML INJECTABLE / INJECTION 1988-07-01 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N016822-001 FREAMINE 8.5% 8.5% (8.5GM/100ML) INJECTABLE / INJECTION Approved before 1982 3f0d92c62455…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N016822-002 FREAMINE II 8.5% 8.5% (8.5GM/100ML) INJECTABLE / INJECTION Approved before 1982 3f0d92c62455…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N016822-003 FREAMINE III 3% W/ ELECTROLYTES 3%;54MG/100ML;40MG/100ML;150MG/100ML;200MG/100ML;120MG/100ML INJECTABLE / INJECTION Approved before 1982 3f0d92c62455…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N016822-004 FREAMINE III 8.5% 8.5% (8.5GM/100ML) INJECTABLE / INJECTION Approved before 1982 3f0d92c62455…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N016822-005 FREAMINE III 10% 10% (10GM/100ML) INJECTABLE / INJECTION Approved before 1982 3f0d92c62455…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N016822-006 FREAMINE HBC 6.9% 6.9% (6.9GM/100ML) INJECTABLE / INJECTION 1983-05-17 3f0d92c62455…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N016822-007 FREAMINE III 8.5% W/ ELECTROLYTES 8.5%;110MG/100ML;230MG/100ML;10MG/100ML;440MG/100ML;690MG/100ML INJECTABLE / INJECTION 1988-07-01 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N016822-001 FREAMINE 8.5% 8.5% (8.5GM/100ML) INJECTABLE / INJECTION Approved before 1982 053a50430f4f…2023-05-13 08:27 UTC 2023-05 N016822-002 FREAMINE II 8.5% 8.5% (8.5GM/100ML) INJECTABLE / INJECTION Approved before 1982 053a50430f4f…2023-05-13 08:27 UTC 2023-05 N016822-003 FREAMINE III 3% W/ ELECTROLYTES 3%;54MG/100ML;40MG/100ML;150MG/100ML;200MG/100ML;120MG/100ML INJECTABLE / INJECTION Approved before 1982 053a50430f4f…2023-05-13 08:27 UTC 2023-05 N016822-004 FREAMINE III 8.5% 8.5% (8.5GM/100ML) INJECTABLE / INJECTION Approved before 1982 053a50430f4f…2023-05-13 08:27 UTC 2023-05 N016822-005 FREAMINE III 10% 10% (10GM/100ML) INJECTABLE / INJECTION Approved before 1982 053a50430f4f…2023-05-13 08:27 UTC 2023-05 N016822-006 FREAMINE HBC 6.9% 6.9% (6.9GM/100ML) INJECTABLE / INJECTION 1983-05-17 053a50430f4f…2023-05-13 08:27 UTC 2023-05 N016822-007 FREAMINE III 8.5% W/ ELECTROLYTES 8.5%;110MG/100ML;230MG/100ML;10MG/100ML;440MG/100ML;690MG/100ML INJECTABLE / INJECTION 1988-07-01 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N016822-001 FREAMINE 8.5% 8.5% (8.5GM/100ML) INJECTABLE / INJECTION Approved before 1982 3bdfa0b2c4d7…2023-01-26 05:58 UTC 2023-01 N016822-002 FREAMINE II 8.5% 8.5% (8.5GM/100ML) INJECTABLE / INJECTION Approved before 1982 3bdfa0b2c4d7…2023-01-26 05:58 UTC 2023-01 N016822-003 FREAMINE III 3% W/ ELECTROLYTES 3%;54MG/100ML;40MG/100ML;150MG/100ML;200MG/100ML;120MG/100ML INJECTABLE / INJECTION Approved before 1982 3bdfa0b2c4d7…2023-01-26 05:58 UTC 2023-01 N016822-004 FREAMINE III 8.5% 8.5% (8.5GM/100ML) INJECTABLE / INJECTION Approved before 1982 3bdfa0b2c4d7…2023-01-26 05:58 UTC 2023-01 N016822-005 FREAMINE III 10% 10% (10GM/100ML) INJECTABLE / INJECTION Approved before 1982 3bdfa0b2c4d7…2023-01-26 05:58 UTC 2023-01 N016822-006 FREAMINE HBC 6.9% 6.9% (6.9GM/100ML) INJECTABLE / INJECTION 1983-05-17 3bdfa0b2c4d7…2023-01-26 05:58 UTC 2023-01 N016822-007 FREAMINE III 8.5% W/ ELECTROLYTES 8.5%;110MG/100ML;230MG/100ML;10MG/100ML;440MG/100ML;690MG/100ML INJECTABLE / INJECTION 1988-07-01 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N016822-001 FREAMINE 8.5% 8.5% (8.5GM/100ML) INJECTABLE / INJECTION Approved before 1982 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N016822-002 FREAMINE II 8.5% 8.5% (8.5GM/100ML) INJECTABLE / INJECTION Approved before 1982 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N016822-003 FREAMINE III 3% W/ ELECTROLYTES 3%;54MG/100ML;40MG/100ML;150MG/100ML;200MG/100ML;120MG/100ML INJECTABLE / INJECTION Approved before 1982 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N016822-004 FREAMINE III 8.5% 8.5% (8.5GM/100ML) INJECTABLE / INJECTION Approved before 1982 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N016822-005 FREAMINE III 10% 10% (10GM/100ML) INJECTABLE / INJECTION Approved before 1982 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N016822-006 FREAMINE HBC 6.9% 6.9% (6.9GM/100ML) INJECTABLE / INJECTION 1983-05-17 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N016822-007 FREAMINE III 8.5% W/ ELECTROLYTES 8.5%;110MG/100ML;230MG/100ML;10MG/100ML;440MG/100ML;690MG/100ML INJECTABLE / INJECTION 1988-07-01 3a93d1ddd44b…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 5 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0264-9010 FreAmine III ISOLEUCINE, LEUCINE, LYSINE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, HISTIDINE, PROLINE, SERINE, GLYCINE, CYSTEINE, PHOSPHORIC ACID, and SODIUM BISULFITE B. Braun Medical Inc. NDA Current 0264-9010 FreAmine III ISOLEUCINE, LEUCINE, LYSINE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, HISTIDINE, PROLINE, SERINE, GLYCINE, CYSTEINE, PHOSPHORIC ACID, and SODIUM BISULFITE B. Braun Medical Inc. NDA Current 0264-9010 FreAmine III ISOLEUCINE, LEUCINE, LYSINE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, HISTIDINE, PROLINE, SERINE, GLYCINE, CYSTEINE, PHOSPHORIC ACID, and SODIUM BISULFITE B. Braun Medical Inc. NDA Current 0264-9350 FreAmine HBC ISOLEUCINE, LEUCINE, LYSINE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, HISTIDINE, PROLINE, SERINE, GLYCINE, CYSTEINE, and SODIUM BISULFITE B. Braun Medical Inc. NDA Current 0264-9350 FreAmine HBC ISOLEUCINE, LEUCINE, LYSINE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, HISTIDINE, PROLINE, SERINE, GLYCINE, CYSTEINE, and SODIUM BISULFITE B. Braun Medical Inc. NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 33200 SUPPL 2004-06-01 13038 SUPPL 2004-06-01